PTC Therapeutics | PTCT - 股本和储备



金融业
股票价格
USD
资产
USD 2.87B
现金及等价物
USD 833.99M
销售成本
USD 39.61M
流动资产
USD 2.25B
流动负债
USD 923.6M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -0.03
股本和储备
USD -180.47M
销售毛利
USD 232.94M
债务利息支出
USD 2.87B
贷款资金
USD 286.94M
市值
USD 5.27B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -2.46M
销售收入
USD 273M
销售和管理费用
USD 73.89M
股票
USD 75.57M
贸易债权人
USD 25.48M
应收帐款人
USD 181.62M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 9.19B 532M 2026-03
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
TG Therapeutics USD 583.13M 64.89M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Xencor USD 515.63M 119.95M 2026-03